Phreesia (PHR) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended January 2025, Phreesia (PHR) reported revenue of $109.68 million, up 15.4% over the same period last year. EPS came in at -$0.11, compared to -$0.56 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $108.91 million, representing a surprise of +0.71%. The company delivered an EPS surprise of +42.11%, with the consensus EPS estimate being -$0.19.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average healthcare services Clients: 4,341 versus the three-analyst average estimate of 4,323. Average revenue per healthcare services client: $17.62 million versus $17.66 million estimated by three analysts on average. Patient payment volume: $1.08 billion versus $1.08 billion estimated by three analysts on average. Payment facilitator volume percentage: 82% versus the two-analyst average estimate of 81.5%. Revenus- Subscription and related services: $51.79 million compared to the $51.70 million average estimate based on six analysts. The reported number represents a change of +13.5% year over year. Revenus- Network solutions: $33.21 million compared to the $32.50 million average estimate based on six analysts. The reported number represents a change of +28.5% year over year. Revenus- Payment processing fees: $24.68 million compared to the $24.71 million average estimate based on six analysts. The reported number represents a change of +5% year over year. View all Key Company Metrics for Phreesia here>>>Shares of Phreesia have returned -18.7% over the past month versus the Zacks S&P 500 composite's -8.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Phreesia, Inc. (PHR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks